Pascal Deschatelets
2017
In 2017, Pascal Deschatelets earned a total compensation of $861K as Chief Operating Officer at Apellis Pharmaceuticals, a 10% decrease compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Option Awards | $461,321 |
| Salary | $279,227 |
| Total | $860,998 |
Deschatelets received $461.3K in option awards, accounting for 54% of the total pay in 2017.
Deschatelets also received $120K in bonus and $279.2K in salary.
Rankings
In 2017, Pascal Deschatelets' compensation ranked 9,696th out of 14,666 executives tracked by ExecPay. In other words, Deschatelets earned more than 33.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,696 out of 14,666 | 34th |
Division Manufacturing | 3,746 out of 5,772 | 35th |
Major group Chemicals And Allied Products | 1,299 out of 2,075 | 37th |
Industry group Drugs | 1,048 out of 1,731 | 40th |
Industry Pharmaceutical Preparations | 826 out of 1,333 | 38th |
Source: SEC filing on April 25, 2018.
Deschatelets' colleagues
We found two more compensation records of executives who worked with Pascal Deschatelets at Apellis Pharmaceuticals in 2017.
News
Apellis Pharmaceuticals CEO Cedric Francois' 2021 pay slips 2% to $9.1M
April 20, 2022
Apellis Pharmaceuticals CEO Cedric Francois' 2020 pay jumps 117% to $9.3M
April 22, 2021
Apellis Pharmaceuticals CEO Cedric Francois' 2019 pay rises 5% to $4.3M
April 22, 2020
Apellis Pharmaceuticals CEO Cedric Francois' 2018 pay jumps 145% to $4.1M
April 30, 2019